At Vyriad, we are developing the next generation of targeted genetic therapies by engineering viruses, viral vectors and viral envelope glycoproteins to deliver genes directly to targeted cells. This targeting technology facilitates oncolytic virotherapy, in vivo gene therapies and gene editing applications.
We are testing our oncolytic viruses as monotherapies and in combination with immuno-oncology drugs.
Phase 1-2 Clinical Studies are currently active in:
Non-small cell lung cancer
Squamous cell carcinoma of the head and neck
Metastatic colorectal cancer
Breast cancer
Bladder cancer
Other cancer types
Vyriad has clinical research collaboration agreements with Regeneron, Mayo Clinic, and other leading research and medical institutions.
Company Details
- Employees
- 50
- Founded
- -
- Address
- Rochester, Mn 55901, Us
- Phone
- 507-289-0944
- in****@****iad.com
- Industry
- Biotechnology
- Website
- vyriad.com
- HQ
- Rochester, MN
Vyriad Questions
Vyriad's helpline number is 507-289-0944
Vyriad's website is vyriad.com
Vyriad's LinkedIn profile is https://www.linkedin.com/company/vyriad
Vyriad has
50 employees.
View email and phone details for 50
employees at Vyriad.
Vyriad's industry is
Biotechnology
Vyriad's top competitors are
Stemcyte Inc.,
Vertex Biopharm Consulting,
Umoja Biopharma,
Genezen,
Secretome Therapeutics,
Poseida Therapeutics, Inc.,
Miltenyi Biotec,
Obio Tech,
Imanis Life Sciences,
Sarepta Therapeutics.
Vyriad's support email address is info@vyriad.com
Vyriad's categories are Biotechnology
Vyriad's founding year is 2015
